Newsroom ARCHIVE
Welcome to the newsroom archive
of AOP Health
Please find below archived press releases
Press Releases
Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via aop-health@aoporphan.com
AOP Orphan Statement on SARS-CoV-2 and COVID-19
17. 3. 2020
AOP Orphan Pharmaceuticals AG, AOP Orphan IP AG and orphanix GmbH join forces to develop RetinolX to prevent bronchopulmonary dysplasia
13. 5. 2019
AOP Orphan Pharmaceuticals AG and Amomed Pharma GmbH announce the launch of RAPIBLOC® (Landiolol) in Germany and Austria.
19. 6. 2017
AOP Orphan Pharmaceuticals AG announces European “approvable” opinion of its ultra-short acting beta blocker Rapibloc® (Landiolol)
11. 7. 2016
AOP Orphan to be commercialization partner for Canadian pharmaceutical specialist Cardiome
10. 12. 2014
AOP Orphan to market the innovative antiarrhythmic drug BRINAVESS® exclusively in Central Europe
25. 8. 2014